Primary plasma cell leukemia: evaluation of a rare disease

Yıl 2015, Cilt: 12 Sayı: 2, 300 - 302, 30.08.2015

Fatma Mutlu Sarıguzel , Bilal Aygun Çiğdem Karakukcu Vedat Arsav Derya Kocer Ahmet Godekmerdan

Öz

Plasma cell leukemia (PCL) is a rare and aggressive cancer involving plasma cells. There are two forms of
PCL (with or without multiple myeloma). Although patients with primary and secondary PCL share several
clinical features, important differences exist. We report on a case diagnosed with primary PCL. We analyzed
the clinicopathologic and laboratory features of the disease. The aim of this report is to draw attention to PCL.

Anahtar Kelimeler

Plasma cell, primary plasma cell leukemia, multiple myeloma

Primer Plazma Hücreli Lösemi: Nadir Bir Hastalığın Değerlendirilmesi

Öz

Plazma hücreli lösemi (PHL), plazma hücrelerini içeren agresif ve nadir görülen bir kanserdir. PHL, multle
myelomanın birlikte olduğu ve olmadığı şekilde iki formu (primer, seconder) bulunmaktadır. Primer ve
seconder PHL'li olguların birçok klinik özellikleri benzer olsada önemli farklılıklar bulunmaktadır. Bu olgu
sunumunda primer PHL'li bir hastanın klinik, patolojik ve laboratuar bulguları incelenmiştir. Bu olgu
sunumunun amacı PHL'e dikkat çekmektir. 

Anahtar Kelimeler

Plazma hücresi, primer plazma hücreli lösemi, multiple myeloma diskoid

Kaynakça

• 1- Dimopoulos MA, Palumbo A, Delasalle KB, Alexanian R. Primary plasma cell leukemia. Br J Haematol 1994; 44: 754-9. 2- Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med 1974; 133: 813-8. 3- Garcia-Sanz R, Orfao A, Gonzalez M, Tabernero MD, Blade J, Moro MJ et al. Primary plasma cell leukemia: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood 1999; 93: 1032-37. 4- Candoni A, Tiribelli M, Fanin R. Plasma cell leukemia occuring in a patient with thrombocythemia treated with hydroxyurea and busulphan. Leuk Lymph 2004; 45: 821- 824. 5- Jain D, Singh T, Akhila L, Ghosh N. Primary plasma cell leukemia in a 30-year-old woman. Indian J Pathol Microbiol 2008; 51: 456-7. 6- Van de Donk NWCJ, Lokhorst HM, Anderson KC, Richardson PG. How I treat plasma cell leukemia. Blood 2012; 120: 2376-89. 7- Van Camp B, Durie BGM, Spier C, De Waele M, Van Riet I, Vela E et al. Plasma cells in multiple myeloma Express a natural killer cell-associated antigen: CD56 (NKH-1, Leu-19). Blood 1990; 76:377. 8- San Miguel JF, Gonzalez M, Gascon A, Moro MJ, Hernandez JM, Ortega F et al. Immunophenotype heterogeneity of multiple myeloma: Influence on the biology and clinical course of the disease. Br J Haematol 1991; 77: 185. 9- Tembhare PR, Subramanian PG, Sehgal K, Yajamanam B, Kumar A, Gadge V et al. Immunophenotypic profile of plasma cell leukemia: a retrospective study in a reference cancer center in India and rewiew of literature. Indian J Pathol Microbiol 2011; 54: 294-8. 10- Goyal M, Mohammad N, Palanki SD, Vaniawala SN. Primary plasma cell leukemia with light chain secretion and multiple chromosomal abnormalities: how successfully treated? Acase report with rewiev of literature. Indian J Med Paediatr Oncol 2010; 31: 96-100.